{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:15:02Z","timestamp":1791328502568,"version":"4.3.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.canlet.2014.09.016","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T06:01:56Z","timestamp":1410847316000},"page":"54-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["P5 HER2\/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer"],"prefix":"10.1016","volume":"355","author":[{"given":"Sheida","family":"Shariat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Badiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Amir","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedeh","family":"Mansourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Alireza","family":"Mortazavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Reza","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2014.09.016_bib0010","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.342.6165.1432","article-title":"Breakthrough of the year 2013. Cancer immunotherapy","volume":"342","author":"Couzin-Frankel","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.canlet.2014.09.016_bib0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1074-7613(00)00026-1","article-title":"Eradication of established tumors by CD8+ T cell adoptive immunotherapy","volume":"13","author":"Hanson","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2014.09.016_bib0020","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/intimm\/dxg078","article-title":"Successful elimination of large established tumors and avoidance of antigen-loss variants by aggressive adoptive T cell immunotherapy","volume":"15","author":"Matsui","year":"2003","journal-title":"Int. Immunol"},{"key":"10.1016\/j.canlet.2014.09.016_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-immunol-100311-102839","article-title":"Decisions about dendritic cells: past, present, and future","volume":"30","author":"Steinman","year":"2012","journal-title":"Annu. Rev. Immunol"},{"key":"10.1016\/j.canlet.2014.09.016_bib0030","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.coi.2013.05.001","article-title":"Human dendritic cell subsets in vaccination","volume":"25","author":"Palucka","year":"2013","journal-title":"Curr. Opin. Immunol"},{"key":"10.1016\/j.canlet.2014.09.016_bib0035","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(00)04904-7","article-title":"An overview of the immune system","volume":"357","author":"Parkin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2014.09.016_bib0040","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.vaccine.2012.01.070","article-title":"Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens","volume":"30","author":"Watson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.canlet.2014.09.016_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(91)90120-5","article-title":"Liposomes as carriers of antigens and adjuvants","volume":"140","author":"Alving","year":"1991","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.canlet.2014.09.016_bib0050","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1517\/17425240903018863","article-title":"Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators","volume":"6","author":"Nordly","year":"2009","journal-title":"Expert Opin. Drug Deliv"},{"key":"10.1016\/j.canlet.2014.09.016_bib0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/978-1-4615-1823-5_21","article-title":"Monophosphoryl lipid A as an adjuvant. Past experiences and new directions","volume":"6","author":"Ulrich","year":"1995","journal-title":"Pharm. Biotechnol"},{"key":"10.1016\/j.canlet.2014.09.016_bib0060","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0171-2985(11)80355-4","article-title":"Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants","volume":"187","author":"Alving","year":"1993","journal-title":"Immunobiology"},{"key":"10.1016\/j.canlet.2014.09.016_bib0065","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","article-title":"Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant","volume":"65","author":"Casella","year":"2008","journal-title":"Cell. Mol. Life Sci"},{"key":"10.1016\/j.canlet.2014.09.016_bib0070","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4161\/onci.20931","article-title":"Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy","volume":"1","author":"Vacchelli","year":"2012","journal-title":"Oncoimmunology"},{"issue":"Suppl. 2","key":"10.1016\/j.canlet.2014.09.016_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000055396","article-title":"Biology of HER2 and its importance in breast cancer","volume":"61","author":"Yarden","year":"2001","journal-title":"Oncology"},{"key":"10.1016\/j.canlet.2014.09.016_bib0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00262-005-0692-3","article-title":"Immunogenic HER-2\/neu peptides as tumor vaccines","volume":"55","author":"Baxevanis","year":"2006","journal-title":"Cancer Immunol. Immunother"},{"key":"10.1016\/j.canlet.2014.09.016_bib0085","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.nano.2011.09.010","article-title":"Induction of tumor-specific immunity by multi-epitope rat HER2\/neu-derived peptides encapsulated in LPD nanoparticles","volume":"8","author":"Jalali","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.canlet.2014.09.016_bib0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0167-4781(99)00140-2","article-title":"A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides","volume":"1489","author":"Levin","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2014.09.016_bib0095","first-page":"15","article-title":"Optimization of a method to prepare liposomes containing HER2\/neu- derived peptide as a vaccine delivery system for breast cancer","volume":"13","author":"Shariat","year":"2014","journal-title":"Iran. J. Pharm. Res"},{"key":"10.1016\/j.canlet.2014.09.016_bib0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/abio.1997.2216","article-title":"The release and detection of endotoxin from liposomes","volume":"250","author":"Harmon","year":"1997","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.canlet.2014.09.016_bib0105","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0021-9258(18)70226-3","article-title":"Phosphorus assay in column chromatography","volume":"234","author":"Bartlett","year":"1959","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2014.09.016_bib0110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0022-1759(94)90110-4","article-title":"CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity","volume":"172","author":"Lichtenfels","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.canlet.2014.09.016_bib0115","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1002\/anie.200900111","article-title":"Disterolphospholipids: nonexchangeable lipids and their application to liposomal drug delivery","volume":"48","author":"Huang","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl"},{"key":"10.1016\/j.canlet.2014.09.016_bib0120","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1158\/1078-0432.CCR-05-1566","article-title":"Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models","volume":"12","author":"Schluep","year":"2006","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2014.09.016_bib0125","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol"},{"key":"10.1016\/j.canlet.2014.09.016_bib0130","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0008-8749(80)90165-3","article-title":"H-2 antigens incorporated into phospholipid vesicles elicit specific allogeneic cytotoxic T lymphocytes","volume":"55","author":"Hale","year":"1980","journal-title":"Cell. Immunol"},{"key":"10.1016\/j.canlet.2014.09.016_bib0135","first-page":"1","article-title":"Liposome facilitated xenogeneic approach for studying human colon cancer immunity: carrier and adjuvant effect of liposomes","volume":"55","author":"Raphael","year":"1984","journal-title":"Clin. Exp. Immunol"},{"key":"10.1016\/j.canlet.2014.09.016_bib0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/0-387-24180-9_12","article-title":"The innate functions of dendritic cells in peripheral lymphoid tissues","volume":"560","author":"Steinman","year":"2005","journal-title":"Adv. Exp. Med. Biol"},{"key":"10.1016\/j.canlet.2014.09.016_bib0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0022-1759(91)90142-3","article-title":"pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein","volume":"141","author":"Reddy","year":"1991","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.canlet.2014.09.016_bib0150","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1084\/jem.175.2.609","article-title":"Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro","volume":"175","author":"Nair","year":"1992","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.canlet.2014.09.016_bib0155","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1016\/S0264-410X(01)00104-9","article-title":"Development of Th1-mediated CD8+ effector T cells by vaccination with epitope peptides encapsulated in pH-sensitive liposomes","volume":"19","author":"Chang","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.canlet.2014.09.016_bib0160","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1006\/viro.1997.8922","article-title":"Induction of V3-specific cytotoxic T lymphocyte responses by HIV gag particles carrying multiple immunodominant V3 epitopes of gp120","volume":"240","author":"Luo","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.canlet.2014.09.016_bib0165","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1016\/S0006-3495(97)78336-X","article-title":"The mechanism of lamellar-to-inverted hexagonal phase transitions in phosphatidylethanolamine: implications for membrane fusion mechanisms","volume":"73","author":"Siegel","year":"1997","journal-title":"Biophys. J."},{"key":"10.1016\/j.canlet.2014.09.016_bib0170","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1073\/pnas.81.6.1715","article-title":"pH-sensitive liposomes: acid-induced liposome fusion","volume":"81","author":"Connor","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2014.09.016_bib0175","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1021\/bi00334a004","article-title":"Proton-induced fusion of oleic acid-phosphatidylethanolamine liposomes","volume":"24","author":"D\u00fczg\u00fcnes","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.canlet.2014.09.016_bib0180","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S1359-6446(03)02864-2","article-title":"Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity","volume":"8","author":"Marciani","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.canlet.2014.09.016_bib0185","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrmicro1681","article-title":"The perfect mix: recent progress in adjuvant research","volume":"5","author":"Guy","year":"2007","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.canlet.2014.09.016_bib0190","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1586\/erv.11.21","article-title":"Trends in vaccine adjuvants","volume":"10","author":"Schijns","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.canlet.2014.09.016_bib0195","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1016\/S0264-410X(03)00172-5","article-title":"Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2\/neu-derived peptide co-encapsulated in liposomes","volume":"21","author":"Li","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.canlet.2014.09.016_bib0200","first-page":"1289","article-title":"Generation of immunity to the HER-2\/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine","volume":"5","author":"Disis","year":"1999","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2014.09.016_bib0205","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1172\/JCI11752","article-title":"Immunization with a HER-2\/neu helper peptide vaccine generates HER-2\/neu CD8 T-cell immunity in cancer patients","volume":"107","author":"Knutson","year":"2001","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.canlet.2014.09.016_bib0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.smim.2004.02.008","article-title":"Immunological memory in humans","volume":"16","author":"Crotty","year":"2004","journal-title":"Semin. Immunol"},{"key":"10.1016\/j.canlet.2014.09.016_bib0215","first-page":"6438","article-title":"Antigen-specific CD4+ T-cell help is required to activate a memory CD8+ T cell to a fully functional tumor killer cell","volume":"62","author":"Gao","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2014.09.016_bib0220","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1517\/14712598.4.7.1129","article-title":"Taking a Toll on human disease: toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents","volume":"4","author":"Baldridge","year":"2004","journal-title":"Expert Opin. Biol. Ther"},{"key":"10.1016\/j.canlet.2014.09.016_bib0225","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/intimm\/12.6.807","article-title":"The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells","volume":"12","author":"De Becker","year":"2000","journal-title":"Int. Immunol"},{"key":"10.1016\/j.canlet.2014.09.016_bib0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001429","article-title":"Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection","volume":"5","author":"Mazumder","year":"2011","journal-title":"PLoS Negl. Trop. Dis"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438351400528X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438351400528X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T02:58:40Z","timestamp":1650164320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438351400528X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S030438351400528X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2014.09.016","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P5 HER2\/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2014.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}